{"id":"https://openalex.org/W1472371601","doi":"https://doi.org/10.1096/fasebj.29.1_supplement.930.7","title":"2\u2010Substituted Aryltropane Cocaine Analogs Produce Atypical DAT Inhibitor Effects without Inducing Inward\u2010Facing DAT Conformations","display_name":"2\u2010Substituted Aryltropane Cocaine Analogs Produce Atypical DAT Inhibitor Effects without Inducing Inward\u2010Facing DAT Conformations","publication_year":2015,"publication_date":"2015-04-01","ids":{"openalex":"https://openalex.org/W1472371601","doi":"https://doi.org/10.1096/fasebj.29.1_supplement.930.7","mag":"1472371601"},"language":"en","primary_location":{"id":"doi:10.1096/fasebj.29.1_supplement.930.7","doi":"https://doi.org/10.1096/fasebj.29.1_supplement.930.7","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.29.1_supplement.930.7","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5107770795","display_name":"Weimin Conrad Hong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Weimin Hong","raw_affiliation_strings":["Psychobiology Section NIDA IRP Baltimore Maryland United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychobiology Section NIDA IRP Baltimore Maryland United States","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067428741","display_name":"Theresa A. Kopajtic","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Theresa Kopajtic","raw_affiliation_strings":["Psychobiology Section NIDA IRP Baltimore Maryland United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychobiology Section NIDA IRP Baltimore Maryland United States","institution_ids":["https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101954590","display_name":"Lifen Xu","orcid":"https://orcid.org/0000-0002-9355-981X","observed_orcids":["https://orcid.org/0000-0002-9355-981X"]},"institutions":[{"id":"https://openalex.org/I192396691","display_name":"LSU New Orleans","ror":"https://ror.org/034mtvk83","country_code":"US","type":"education","lineage":["https://openalex.org/I192396691"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lifen Xu","raw_affiliation_strings":["Chemistry University of New Orleans New Orleans LA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemistry University of New Orleans New Orleans LA United States","institution_ids":["https://openalex.org/I192396691"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053612109","display_name":"Stacey A. Lomenzo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I192396691","display_name":"LSU New Orleans","ror":"https://ror.org/034mtvk83","country_code":"US","type":"education","lineage":["https://openalex.org/I192396691"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stacey Lomenzo","raw_affiliation_strings":["Chemistry University of New Orleans New Orleans LA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemistry University of New Orleans New Orleans LA United States","institution_ids":["https://openalex.org/I192396691"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021587350","display_name":"Mark L. Trudell","orcid":"https://orcid.org/0000-0001-6201-0253","observed_orcids":["https://orcid.org/0000-0001-6201-0253"]},"institutions":[{"id":"https://openalex.org/I192396691","display_name":"LSU New Orleans","ror":"https://ror.org/034mtvk83","country_code":"US","type":"education","lineage":["https://openalex.org/I192396691"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Trudell","raw_affiliation_strings":["Chemistry University of New Orleans New Orleans LA United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemistry University of New Orleans New Orleans LA United States","institution_ids":["https://openalex.org/I192396691"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053763901","display_name":"Jonathan L. Katz","orcid":"https://orcid.org/0000-0002-1068-1159","observed_orcids":["https://orcid.org/0000-0002-1068-1159"]},"institutions":[{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan Katz","raw_affiliation_strings":["Psychobiology Section NIDA IRP Baltimore Maryland United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychobiology Section NIDA IRP Baltimore Maryland United States","institution_ids":["https://openalex.org/I1327069482"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3740,"currency":"USD","value_usd":3740},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.02281803,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"29","issue":"S1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.006399999838322401,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cocaine-analogs","display_name":"cocaine analogues","score":0.8920000195503235},{"id":"https://openalex.org/keywords/dopamine-transporter","display_name":"dopamine transporter","score":0.7570000290870667},{"id":"https://openalex.org/keywords/locomotor-activity","display_name":"locomotor activity","score":0.8080000281333923},{"id":"https://openalex.org/keywords/cocaine-discrimination","display_name":"cocaine discrimination","score":0.5910000205039978},{"id":"https://openalex.org/keywords/cysteine-accessibility","display_name":"cysteine accessibility","score":0.8600000143051147},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.6299999952316284},{"id":"https://openalex.org/keywords/stereoselectivity","display_name":"stereoselectivity","score":0.6790000200271606}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7977427244186401},{"id":"https://openalex.org/C2776755682","wikidata":"https://www.wikidata.org/wiki/Q2271947","display_name":"Dopamine transporter","level":4,"score":0.7651669383049011},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5978598594665527},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5246020555496216},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.4983534812927246},{"id":"https://openalex.org/C486523","wikidata":"https://www.wikidata.org/wiki/Q494483","display_name":"Enantiomer","level":2,"score":0.46452200412750244},{"id":"https://openalex.org/C2910393698","wikidata":"https://www.wikidata.org/wiki/Q415026","display_name":"Benztropine","level":3,"score":0.4366511404514313},{"id":"https://openalex.org/C149011108","wikidata":"https://www.wikidata.org/wiki/Q652985","display_name":"Transporter","level":3,"score":0.40142861008644104},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.26278549432754517},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.191025048494339},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.13896501064300537},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.11066633462905884},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1096/fasebj.29.1_supplement.930.7","doi":"https://doi.org/10.1096/fasebj.29.1_supplement.930.7","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fasebj.29.1_supplement.930.7","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8048999905586243}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/10","display_name":"Reduced inequalities","score":0.699999988079071}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2427320793","https://openalex.org/W2810385975","https://openalex.org/W2103896969","https://openalex.org/W2007806021","https://openalex.org/W2019313771","https://openalex.org/W2773703335","https://openalex.org/W1980014219","https://openalex.org/W2027128305","https://openalex.org/W2061828367","https://openalex.org/W2039116048"],"abstract_inverted_index":{"Previous":[0,134],"structure\u2010activity":[1],"studies":[2],"indicated":[3],"that":[4,137,178,196,215],"a":[5,131,184],"series":[6],"of":[7,40,43,45,87,103,109,118,122,156,165,187,219],"cocaine":[8,39,58,65,138,157,210],"analogs":[9,124,198],"(3\u00df\u2010aryltropanes":[10],"with":[11,21,25,183],"various":[12],"2\u00df\u2010diarylmethoxy":[13],"substitutions)":[14],"selectively":[15],"bind":[16,200],"the":[17,36,72,88,94,104,115,123,166,202],"dopamine":[18],"transporter":[19],"(DAT)":[20],"nM":[22],"affinity,":[23],"and":[24,55,168,192,204,211],"corresponding":[26],"2\u03b1\u2010enantiomers":[27],"having":[28],"10\u2010fold":[29],"lower":[30],"affinity.":[31],"The":[32],"present":[33],"study":[34,186],"assessed":[35,129],"similarity":[37],"to":[38,177,201],"behavioral":[41,151,191],"effects":[42,50,121,152,214],"several":[44],"these":[46,110,119,190],"compounds":[47,90,106,170],"by":[48,159,180],"examining":[49],"on":[51,125],"locomotion":[52],"in":[53,62],"mice":[54],"substitution":[56],"for":[57,81],"(10":[59],"mg/kg,":[60],"ip)":[61],"rats":[63],"discriminating":[64],"from":[66,154,217],"saline.":[67],"Despite":[68],"DAT":[69,126,142,174,203,207],"affinity":[70],"only":[71,93],"2\u03b2\u2010Ph":[73],"2":[74,76,96],"COCH":[75],"\u20103\u00df\u20104\u2010Cl\u2010Ph":[77,97],"analog":[78,98],"fully":[79],"substituted":[80],"cocaine's":[82],"discriminative":[83],"effects.":[84,112],"Whereas":[85],"all":[86],"2\u03b2":[89],"increased":[91],"locomotion,":[92],"2\u03b2\u2010(4\u2010ClPh)PhCOCH":[95],"had":[99],"cocaine\u2010like":[100,111],"efficacy.":[101],"None":[102],"2\u03b1\u2010substituted":[105,169],"produced":[107],"either":[108],"To":[113],"explore":[114],"molecular":[116],"mechanisms":[117],"drugs,":[120],"conformation":[127,175],"were":[128],"using":[130],"cysteine\u2010accessibility":[132],"assay.":[133],"results":[135,194],"suggest":[136],"induces":[139],"an":[140,161,172],"outward\u2010facing":[141,173,206],"conformation,":[143],"whereas":[144],"atypical":[145],"DAT\u2010inhibitors,":[146],"such":[147],"as":[148],"benztropine,":[149],"produce":[150,213],"distinct":[153],"those":[155,218],"presumably":[158],"inducing":[160],"inward\u2010facing":[162],"conformation.":[163],"Most":[164],"2\u03b2\u2010":[167],"induced":[171,179],"similar":[176],"cocaine.":[181,220],"Consistent":[182],"previous":[185],"phenyltropane":[188,197],"analogs,":[189],"biochemical":[193],"show":[195],"can":[199],"induce":[205],"conformations":[208],"like":[209],"still":[212],"differ":[216]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}